glp 1 agonist small molecule Binding sites and design strategies for GLP-1R agonists Oral Small-Molecule GLP-1 Receptor Agonists:

Semaglutide and other GLP-1 drugs can cause side effects like nausea, diarrhoea, dizziness, stomach pain, and constipation

More receptor coverage = synergistic effects Appetite suppression (via Y2R) layered onto glycemic control & energy expenditure Smart design: lipidation, sequence grafting, and biasing GLP-1R signaling toward cAMP while avoiding -arrestin desensitization These arent just incremental add-ons

For example, research has shown that drinking a blueberry-supplemented smoothie for six weeks can enhance insulin sensitivity in people with obesity and insulin resistance

doi: 10.3389/fendo.2021.645563 25 HughesSNeumillerJJ

Wollenhaupt-Aguiar B, Kapczinski F, Pfaffenseller B

Big Pharma is winning the war for market share but theyre still losing patients to the underground